重大活動
WHX Labs Cape Town
GBC at WHX Labs Cape Town 2025: Accelerating Liquid Biopsy and Precision Diagnostics in Africa
Event Overview
WHX Labs Cape Town 2025, held from 2–4 September 2025 at CTICC, is Africa’s leading medical laboratory and diagnostics event under the World Health Expo series. It attracted 3,000+ attendees, 350+ exhibitors, and 200+ speakers, covering oncology, infectious diseases, AI-driven diagnostics, and integrated laboratory automation.
GBC’s Showcase Highlights
At Booth H1.D17, GBC demonstrated a complete portfolio of integrated diagnostic solutions:
CellBio™ Liquid Biopsy Systems — automated detection and enrichment of CTCs and CTMs for early cancer screening and precision oncology.
ELISA Reagents — robust assays for infectious disease screening and chronic condition monitoring.
CLIA CL i120 System and Reagents — high-sensitivity solutions for protein, antibody, and hormone testing.
GBC AIO M160 System with Real-Time PCR Kits — all-in-one extraction-to-amplification solutions for infectious diseases and genetic markers.
Self-Collection Device for HPV — enabling patient-friendly, high-compliance cervical cancer screening workflows.
CDMO Services — from biomaterials to finished kits, supporting regional assay co-development.
Key Learnings & Market Insights:
Rising demand for CTC-based oncology workflows — especially from regional cancer centers seeking less-invasive diagnostics.
Growing HPV screening awareness — NGOs and public health networks expressed strong interest in self-collection HPV testing for high-risk groups.
Integrated reagents & systems appeal — the ability to deliver reagents, analyzers, and CDMO services in one ecosystem differentiated GBC.
Need for regulatory-ready partnerships — African distributors requested support for CE-IVD dossiers and WHO PQ processes to accelerate adoption.
